Treatment of Crohn's disease patients with infliximab is detrimental for the survival of Mycobacterium avium ssp. paratuberculosis within macrophages and shows a remarkable decrease in the immunogenicity of mycobacterial proteins

Journal of Crohn's and Colitis

Volumn 6, Issue 5, 2012, Pages 628-629

  Bach, Horacio ^a   Rosenfeld, Greg ^a   Bressler, Brian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; INFLIXIMAB; PROTEIN KINASE; PROTEIN TYROSINE PHOSPHATASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY TITER; BACTERIAL SURVIVAL; CELL DIFFERENTIATION; CROHN DISEASE; CYTOKINE PRODUCTION; HUMAN; IMMUNOGENICITY; LETTER; MACROPHAGE; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; BACTERIAL PROTEINS; CROHN DISEASE; HUMANS; IMMUNOGENETIC PHENOMENA; MACROPHAGES; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; PARATUBERCULOSIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84860838016     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.01.011     Document Type: Letter

References (10)

1. Abubakar I., Myhill D., Aliyu S.H., Hunter P.R. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis 2008, 14(3):401-410.
2. Autschbach F., Eisold S., Hinz U., Zinser S., Linnebacher M., Giese T., et al. High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut 2005, 54(7):944-949.
3. Naser S.A., Ghobrial G., Romero C., Valentine J.F. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 2004, 364(9439):1039-1044.
4. Naser S.A., Schwartz D., Shafran I. Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients. Am J Gastroenterol 2000, 95(4):1094-1095.
5. Clancy R., Ren Z., Turton J., Pang G., Wettstein A. Molecular evidence for Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease correlates with enhanced TNFalpha secretion. Dig Liver Dis 2007, 39(5):445-451.
6. Nakase H., Tamaki H., Matsuura M., Chiba T., Okazaki K. Involvement of Mycobacterium avium subspecies paratuberculosis in TNF-α production from macrophage: possible link between MAP and immune response in Crohn's disease. Inflamm Bowel Dis 2011, 17(2):E140-E142.
7. Bach H., Sun J., Hmama Z., Av-Gay Y. Mycobacterium avium subsp. paratuberculosis PtpA is an endogenous tyrosine phosphatase secreted during infection. Infect Immun 2006, 74(12):6540-6546.
8. Bach H., Ko H.H., Raizman E.A., Attarian R., Cho B., Biet F., et al. Immunogenicity of Mycobacterium avium subsp. paratuberculosis proteins in Crohn's disease patients. Scand J Gastroenterol 2011, 46(1):30-39.
9. Bach H., Papavinasasundaram K.G., Wong D., Hmama Z., Av-Gay Y. Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B. Cell Host Microbe 2008, 3(5):316-322.
10. Walburger A., Koul A., Ferrari G., Nguyen L., Prescianotto-Baschong C., Huygen K., et al. Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science 2004, 304(5678):1800-1804.